Ibu and Cabazitaxel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ibu (ibuprofen) and Cabazitaxel (cabazitaxel). Common drug interactions include hydronephrosis among females and hyperhidrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Ibu and Cabazitaxel. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.

What is Cabazitaxel?

Cabazitaxel has active ingredients of cabazitaxel. eHealthMe is studying from 2,161 Cabazitaxel users. Check the latest studies of Cabazitaxel.

On Jul, 13, 2026

36 people who take Ibu and Cabazitaxel together, and have interactions are studied.

What are the common drug interactions of Ibu and Cabazitaxel, by gender? *:

female:

Hydronephrosis (water inside the kidney)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Neutropenic infection (infection with less neutrophil numbers in blood)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

male:

Hyperhidrosis (abnormally increased sweating)
Pyrexia (fever)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Gastritis (inflammation of stomach)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Asthenia (weakness)
Blood alkaline phosphatase increased
Blood bilirubin increased
Body temperature increased

What are the common drug interactions of Ibu and Cabazitaxel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pneumonitis (inflammation of the walls of the alveoli in the lungs)

40-49:

Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Urinary tract infection
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Gastritis (inflammation of stomach)
Loss of libido (loss of sexual urge)

50-59:

Chills (felling of cold)
Decreased appetite
Hepatitis (inflammation of the liver)
Muscular weakness (muscle weakness)
Disease progression
Hydronephrosis (water inside the kidney)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

60+:

Hyperhidrosis (abnormally increased sweating)
Pyrexia (fever)
Body temperature increased
Cardiac discomfort
Chills (felling of cold)
Constipation
Decreased appetite
Dizziness
Dyspnoea (difficult or laboured respiration)
Febrile infection (infection with temperature rise)

What are the existing conditions these people have? *

Prostate Cancer: 16 people, 44.44%
Prostate Cancer Metastatic: 9 people, 25.00%
Back Pain: 5 people, 13.89%
High Blood Pressure: 3 people, 8.33%
Osteoporosis (bones weak and more likely to break): 3 people, 8.33%
Nausea (feeling of having an urge to vomit): 3 people, 8.33%
Metastases To Bone (cancer spreads to bone): 3 people, 8.33%
Joint Pain: 3 people, 8.33%
Stress And Anxiety: 3 people, 8.33%
Gout (uric acid crystals building up in the body): 3 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and Cabazitaxel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously